Developed using OpenAI’s ChatGPT and trained on healthcare-specific prose, the online DocsGPT offers doctors a chance to test and weigh in on AI-powered product development. Testing AI for workflow ‘scut’
OpenAI developed ChatGPT, which launched in…
Bradi Harrison, the mother of Jack Nathan, who is the Founder of Happy Jack’s World, an online community and apparel brand focusing on mental health, mainly targeting GenZ and younger Millennials joins eHealth and…
Continue Reading
Sachin Agrawal, MSc is CEO of EVisit of Mesa, AZ.
Tell me about yourself and the company.
I’ve been in healthcare consulting and software for 20 years, always focused on the enterprise needs…
Zero Trust and NIST SP 800-207The National Institutes of Standards and Technology brought private and public partnerships together to discuss how to develop a framework to defend against attacks. On Aug. 11, 2020, NIST…
Continue Reading
The National Institute of Standards and Technology says it will publish the Ascon group of algorithms in its lightweight cryptography standard later this year.WHY IT MATTERS
NIST has found “a worthy defender” of data generated by small Internet of Things-connected devices as the result of a four-year international competition, according to the…
Acquisition further advances CVS Health’s care delivery strategy for consumers
CVS Health® (NYSE: CVS) and Oak Street Health (NYSE: OSH) have entered into a definitive agreement under which CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion.
Oak Street Health is…
Melissa Mooney, Director of eCOA Solutions Engineering at IQVIAIn the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the side effects are tolerable for patients and how these treatments could be improved from the patient’s…
Continue Reading
Top News
The VA postpones its planned July 2023 Oracle Cerner go-live at its Ann Arbor, MI facilities until later this year or early in 2024.
The service region is concerned about “how well EHRM would interact with VA Ann Arbor’s vital medical research mission.”
Reader Comments From AT: “Re: pet peeves with service industry words and phrases. ‘I appreciate you,’ following my thanking you and leaving you a tip, which suggests that we are like-minded, decent people even though you have no way of knowing that. Second is thanking someone with ‘of course,” implying that I’m either too stupid to know…
Continue Reading
The challenges of designing effective clinical trials, finding the right people to participate in them and building trial cohorts that are representative of the population at large, have been well-documented.With its recent Life Sciences initiative, Epic has set its sights on data-driven insights to improve the development of new therapeutics and interventions. That includes improving all parts of the clinical trial process – from how physicians educate their patients about potential cohorts, matching and connecting patients with promising research and helping make sure those studies are optimally beneficial for as many people as possible. Epic is already helping its provider customers…
Continue Reading
The Department of Veterans Affairs (VA) will further delay its Oracle Cerner EHR implementation at the agency’s Ann Arbor Healthcare System until late 2023 or early 2024, according to reporting from FedScoop. Laura E….
Continue Reading
